| Literature DB >> 30901177 |
Amir Fattahi1,2, Zeinab Latifi3, Masoud Darabi3, Ali Salmassi2, Laya Farzadi1, Maghsood Shaaker3, Amir Mehdizadeh4, Tohid Ghasemnejad1, Leila Roshangar5, Mohammad Nouri1,2.
Abstract
PURPOSE: No comprehensive information is available about uterus fatty acid (FA) change during implantation period and possible effects of the seminal vesicle secretion on it.Entities:
Keywords: Male; Seminal Vesicles; Uterus
Mesh:
Substances:
Year: 2019 PMID: 30901177 PMCID: PMC6837596 DOI: 10.1590/S1677-5538.IBJU.2018.0485
Source DB: PubMed Journal: Int Braz J Urol ISSN: 1677-5538 Impact factor: 1.541
Fatty acid composition of standard chow pellet.
| Composition | Standard chow |
|---|---|
| 14:0 (%) | 1.1 |
| 16:0 (%) | 40.6 |
| 16:1 (%) | 1.4 |
| 18:0 (%) | 6.8 |
| 18:1 (%) | 28.8 |
| 18:2 (%) | 19.6 |
| 18:3 (%) | 1.4 |
| Carbohydrate | 58 |
| Protein | 28 |
| Fat | 14 |
Data are expressed as percentage (%) of total
Figure 1Embryo implantation sites on the mice uterine horns at the fifth day of pregnancy using Chicago blue dye; the arrows indicate implantation.
Animals and their wet uterine weight as well as uterine weight/body weight ratio on various pregnancy days in control (n=20) and seminal vesicle excised (SVX)-mated (n=20) groups.
| Day 1 | Day 2 | Day 3 | Day 4 | Day 5 | |
|---|---|---|---|---|---|
| Body weight (gr) | 33.82±3.67 | 29.80±3.37 | 33.90±3.04 | 32.40±2.56 | 32.70±1.67 |
| Wet uterine weight (mg) | 142.25±26.66 | 70.25±22.06a | 89.00±12.73a | 88.33±22.68a | 115.00±30.47b |
| (Uterine weight/body weight ratio)×1000 | 4.27±1.14 | 2.41±0.90a | 2.54±0.19a | 2.72±0.43a | 3.49±0.75c |
| Body weight (gr) | 31.97±1.62 | 30.97±0.38 | 30.22±0.94 | 32.50±3.54 | 29.90±3.94 |
| Wet uterine weight (mg) | 124.25±26.41 | 78.75±22.29a | 75.75±26.86a | 118.00±6.68b,c | 139.50±11.12b, c |
| (Uterine weight/body weight ratio)×1000 | 3.90±0.88 | 2.55±0.76a | 2.50±0.85a | 3.65±0.50b,c, $ | 4.69±0.35b,c,d, $ |
Data are shown as Mean ± S.D; Levene’s test confirmed homoscedasticity of variances and two-way ANOVA Was used to evaluate interaction between groups and days.
Significant difference (p<0.05) in comparison with Day 1; Day2; Day 3 and Day 4
Significant difference in comparison with the control group
Fatty acids composition of uterine phospholipids during window of implantation (days 1 to 5 of pregnancy) in intact (control, n=20) and seminal vesicle excised (SVX)-mated (n=20) mice.
| Day 1 | Day 2 | Day 3 | Day 4 | Day 5 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||
| Control | SVX-mated | Control | SVX-mated | Control | SVX-mated | Control | SVX-mated | Control | SVX-mated | |
| 16:0 (%) | 25.24±4.72 | 25.93±5.46 | 27.82±4.44 | 21.56±2.21* | 29.48±3.67 | 24.01±4.65 | 24.21±3.30 | 23.22±3.14 | 21.83±4.43b, c | 21.38±3.16 |
| 16:1 (%) | 3.52±0.76 | 3.17±0.48 | 3.47±1.03 | 4.06±0.81 | 3.72±0.58 | 4.09±0.52 | 4.08±1.25 | 3.89±0.96 | 3.90±1.39 | 4.22±0.95 |
| 18:0 (%) | 24.71±4.58 | 23.15±4.04 | 27.00±3.47 | 23.08±3.20 | 29.33±3.91 | 24.45±3.40 | 24.79±4.95 | 22.92±3.11 | 21.03±3.52 | 23.33±3.53 |
| 18:1 (%) | 21.40±2.26 | 22.62±4.93 | 24.81±3.46 | 27.00±4.44 | 24.84±4.18 | 28.00±4.35 | 24.20±3.31 | 27.10±4.06 | 23.02±4.56 | 25.15±3.46 |
| 18:2 (%) | 11.45±2.76 | 10.70±2.91 | 7.49±0.76 | 10.16±1.91 | 5.29±1.18a | 8.16±1.94* | 10.28±2.80c | 10.00±1.96 | 13.81±2.78b, c, d | 12.06±2.17 |
| 18:3 (%) | 1.85±0.46 | 1.77±0.33 | 1.88±0.17 | 2.63±0.74 | 2.46±0.58 | 2.28±1.04 | 2.42±0.84 | 3.04±1.99 | 2.33±0.40a | 3.44±1.33 |
| 20:4 (%) | 12.00±2.63 | 12.68±2.29 | 7.54±2.43a | 11.55±1.51* | 4.95±2.99a, b | 9.00±1.32* | 9.82±1.92a, c | 10.32±2.06 | 14.20±2.40b, c, d | 10.40±1.75* |
| SFA (%) | 49.96±2.91 | 49.08±1.44 | 54.82±1.82 | 44.64±1.47* | 58.82±4.66a | 48.46±6.07* | 49.00±2.81c | 46.14±5.53 | 42.87±1.37a, b, c | 44.71±6.62 |
| MUFA (%) | 24.93±1.93 | 25.79±5.24 | 28.28±3.11a | 31.06±3.77 | 28.56±4.15a | 32.09±4.67 | 28.28±3.73a | 30.99±4.93 | 26.91±4.48 | 29.37±4.21 |
| PUFA (%) | 25.31±2.59 | 25.15±4.06 | 16.92±1.72a | 24.34±3.30* | 12.70±2.71a, b | 19.45±3.13* | 22.74±2.25c | 22.86±1.86 | 30.28±5.20b, c, d | 25.90±2.66 |
| SFA/UFA (%) | 1.00±0.12 | 0.96±0.05 | 1.21±0.08 | 0.80±0.05* | 1.45±0.30a, b | 0.96±0.23* | 0.96±0.10c | 0.87±0.21 | 0.75±0.04a, b, c | 0.83±0.22 |
Data are shown as Mean ± S.D; SFA = saturated fatty acids; MUFA = mono-unsaturated fatty acids; PUFA = poly-unsaturated fatty acids; SFA/UFA = ratio of saturated to unsaturated fatty acids; Levene's test confirmed homoscedasticity of variances and two-way ANOVA was used to evaluate interaction between groups and days; Significant difference (p<0.05) in comparison with Day1, Day2, Day3, Day4 and * between the groups at same day.
Figure 2Correlation between implantation rate with a) arachidonic acid (ARA) and b) polyunsaturated fatty acid (PUFA) levels on the fifth day of pregnancy in the control mice.